TechNation Radio Podcast

On this week’s Tech Nation, from the bumpy history of the chariot to how smartphones are essential equipment for transportation in the future. Economist deputy editor Tom Standage talks about “A Brief History of Motion: From the Wheel, to the Car, to What Comes Next”. Then Dr. Jim Brown, the CEO of DURECT, describes their first Phase 2 clinical trials for Alcoholic Hepatitis, known as AH. And a look at what comes next for their approach to regenerative medicine.

On this week’s Tech Nation, it’s about developing medicines which enable the body to heal itself. First up, treating depression in a whole new way … and rapidly. Dr. Jeff Jonas, the Chief Innovation Officer and Director of Sage Therapeutics, talks about their drug Zuranolone, nearing the end of its drug approval journey. Then, Craig Parker, the CEO of Surrozen, talks about their work with the W-N-T pathway, or Wnt pathway. Their initial candidate for treatment? Repairing the liver.

On this week’s Tech Nation, it’s about developing medicines which enable the body to heal itself. First up, treating depression in a whole new way … and rapidly. Dr. Jeff Jonas, the Chief Innovation Officer and Director of Sage Therapeutics, talks about their drug Zuranolone, nearing the end of its drug approval journey. Then, Craig Parker, the CEO of Surrozen, talks about their work with the W-N-T pathway, or Wnt pathway. Their initial candidate for treatment? Repairing the liver.

On this week’s Tech Nation, Moira speaks with ROBERT SIEGEL, Venture Investor and Stanford University Lecturer, and the Author of “The Brains and Brawn Company … How Leading Organizations blend the best of Digital and Physical.” Then, intervening with “cytokine storms”. JIM JOYCE, the CEO of San Diego’s Sigyn Therapeutics talks about their progress to intervening quickly.

On this week’s Tech Nation, Moira speaks with ROBERT SIEGEL, Venture Investor and Stanford University Lecturer, and the Author of “The Brains and Brawn Company … How Leading Organizations blend the best of Digital and Physical.” Then, intervening with “cytokine storms”. JIM JOYCE, the CEO of San Diego’s Sigyn Therapeutics talks about their progress to intervening quickly.

On this week’s Tech Nation, Moira speaks with journalist Oliver Broudy about his book “The Sensitives - The Rise of Environmental Illness and Search for America’s Last Pure Place.” Then in biotech, a San Diego company who pivoted from treating parainfluenza and influenza to target COVID … and they started in Wuhan, China. Moira speaks with Dr. Stanley Lewis, the Chief Medical Officer of Ansun Biopharma.

Moira speaks with journalist Jason Fagone talks about Elizebeth Smith Friedman, a pioneer in codebreaking, from World War I to rumrunners to drug smuggling to the famous Enigma machine. His book is “The Woman Who Smashed Codes: A True Story of Love, Spies, and the Unlikely Heroine Who Outwitted America’s Enemies.”

Then on Tech Nation Health, Dr. Marco Taglietti, President and CEO of Scynexis, talks about their work in serious invasive fungal infections.

Moira speaks with journalist Jason Fagone talks about Elizebeth Smith Friedman, a pioneer in codebreaking, from World War I to rumrunners to drug smuggling to the famous Enigma machine. His book is “The Woman Who Smashed Codes: A True Story of Love, Spies, and the Unlikely Heroine Who Outwitted America’s Enemies.”

On this week’s Tech Nation, Moira speaks with DR. HARVEY KAUFMAN, the Senior Medical Director of Quest Diagnostics, about how the use or delay of medical tests reveals about the health status of the US. Then MIKE CLAYMAN, the CEO of Flexion Therapeutics, talks about the treatments they have in clinical trials for osteoarthritis, knee replacement surgery, and more.

On this week’s Tech Nation, Moira speaks with DR. HARVEY KAUFMAN, the Senior Medical Director of Quest Diagnostics, about how the use or delay of medical tests reveals about the health status of the US. Then MIKE CLAYMAN, the CEO of Flexion Therapeutics, talks about the treatments they have in clinical trials for osteoarthritis, knee replacement surgery, and more.